Envoy Medical (COCH) Research & Development (2022 - 2026)

Envoy Medical has disclosed Research & Development across 5 years of filings, most recently posting $3.1 million for Q2 2026.

• In Q2 2026, Research & Development rose 26.04% year-over-year to $3.1 million; the TTM figure through Jun 2026 stood at $14.0 million (up 34.09% YoY), while the FY2025 annual figure was $12.5 million, up 22.66% from the prior year.
• Research & Development came in at $3.1 million for Q2 2026 at Envoy Medical, down from $3.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $4.6 million in Q4 2025 to a low of $935000.0 in Q3 2022.
• Average Research & Development over 5 years is $2.6 million, with a median of $2.5 million recorded in 2024.
• Year-over-year, Research & Development surged 111.71% in 2023 and declined 19.12% in 2024.
• Over 5 years, Research & Development stood at $1.4 million in 2022, then jumped by 111.71% to $3.1 million in 2023, then decreased by 19.12% to $2.5 million in 2024, then jumped by 84.26% to $4.6 million in 2025, then tumbled by 31.21% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $3.1 million in Q2 2026, $3.6 million in Q1 2026, and $4.6 million in Q4 2025.